Publisher
Computers, Materials and Continua (Tech Science Press)
Reference31 articles.
1. Azzoli CG, Baker S, Temin S, Pao W, Aliff T, Brahmer J et al. (2009) American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small cell lung cancer. J Clin Oncol 27: 6251–6266
2. Azzoli CG, Temin S, Aliff T et al. (2011) 2011 Focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 29: 3825–3831
3. Barlesi F, de Castro J, Dvornichenko V et al. (2011) Final efficacy outcomes for patients with advanced non-small cell lung cancer randomized to continuation maintenance with bevacizumab or bevacizumab + pemetrexed after first-line bevacizumab-cisplatin-pemetrexed treatment. Eur J Cancer 47(Suppl 1): LBA34
4. Behara M, Owonikoko TK, Chen Z et al. (2011) Single-agent maintenance therapy for advanced-stage non-small cell lung cancer: a meta-analysis. J Clin Oncol 29: 18s (suppl: abst 7553)
5. Belani C, Barstis J, Perry MC, et al. (2003) Multicenter, randomized trial for stage IIIB or IV non-small cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation. J Clin Oncol 21: 2933–2939